LANL

EDGE cobbles together several open-source tools into simple pipelines for sequence assembly, taxonomic classification, phylogenetic analysis, and other tasks.

NEW YORK (GenomeWeb) — Early-stage molecular diagnostics developer Mesa Tech International has been awarded $1 million from the National Institutes of Health to further develop its low-cost nucleic acid testing device for respiratory disease diagnosis.

By encapsulating single organisms from microbiome samples in gel microdroplets and then culturing them to form microcolonies, researchers from the Los Alamos National Laboratory have been able to sequence the genomes of individual bacterial species with much higher coverage and l

By Monica Heger

This article was originally published March 19.

Patrick Chain, leader of the metagenomics applications team at Los Alamos National Laboratory, was the first author on a recent policy paper that proposed a new set of standards describing the quality of genome sequences.

The flow cytometer uses sound waves to control the movement of cells, and is the first entry in the flow cytometry instrumentation market for Applied Biosystems and parent company Life Technologies.

Biomagnetics Diagnostics intends to develop a handheld, integrated optical biosensor for rapid diagnosis of HIV/AIDS, malaria, tuberculosis, and other pathogens.

Researchers from Los Alamos National Laboratory, the University of California at Los Angeles, and Agilent have designed an automated, high-throughput genotyping system for detecting potential pathogens.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.